Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Simplivia Healthcare
Simplivia Healthcare Overview
Simplivia Healthcare develops and manufactures high-quality drug-delivery solutions to ensure the safety of healthcare professionals.
Simplivias Tevadaptor and Chemfort products use the companys patented Toxi-Guard system, located in the vial adaptor, to allow pressure equalization during use, preventing the escape of hazardous drug vapors into the environment during drug reconstitution and administration as well as preventing airborne contaminants and particles from entering the drug vial.
Tevadaptor was formerly a business unit in Teva Pharmaceutical Industries. In May 2019, Simplivia Healthcare incorporated Tevadaptor after the business unit was acquired by FIMI Opportunity Funds, an Israeli private equity firm.
In the U.S., Simplivias products are distributed exclusively by B. Braun under the brand name OnGuard. Tevadaptor and Chemfort are approved by the worlds leading regulatory bodies. The companys manufacturing facility in Kiryat Shmona, Israel, meets the most rigorous standards, with both FDA and CE approval.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Simplivia Healthcare Climate Tech relevance
undefined
Latest News
No Data, yet.
Sorry, no content found under this section.
Feb 10, 2022
www.calcalist.co.il
פימי תנפיק את סימפליויה בשווי של פי 7 לעומת הרכישה מטבע כלכליסט
#Investment, Public Trading
Jan 5, 2021
en.globes.co.il
Simplivia Healthcare buys diagnostics co Novamed
#Acquisition
Oct 22, 2020
en.globes.co.il
FIMI sells 33% of medical equipment co Simplivia
#Acquisition
May 1, 2019
en.globes.co.il
FIMI completes acquisition of Teva's Kiryat Shmona plant